Evidence map›Paper›PMID 30951583›Full record

ArticleBiology of reproduction2019

Matrix metalloproteinases 2 and 9 are elevated in human preterm laboring uterine myometrium and exacerbate uterine contractility†.

Craig C Ulrich, Veronica Arinze, Carolina Bueno Wandscheer, Christian Copley Salem, Camellia Nabati, Neda Etezadi-Amoli, Heather R Burkin

Open access · bronzeAbstract read
In one paragraph

Article in Biology of reproduction, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Matrix Metallopeptidase 9 Promotes Contraction in Human Uterine Myometrium.Reproductive sciences (Thousand Oaks, Calif.) · 2025
    Article
  6. A bioprinted model of pregnant human uterine myometrium.Frontiers in bioengineering and biotechnology · 2025
    Article
  7. Clinical chorioamnionitis at term is characterized by changes in the plasma concentration of CHCHD2/MNRR1, a mitochondrial protein.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. TNF-Expert reviews in molecular medicine · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Craig C UlrichUniversity of Nevada, Reno School of Medicine, Department of Pharmacology, Reno, Nevada, USA.
Veronica ArinzeUniversity of Nevada, Reno School of Medicine, Department of Pharmacology, Reno, Nevada, USA.
Carolina Bueno WandscheerUniversity of Nevada, Reno School of Medicine, Department of Pharmacology, Reno, Nevada, USA.
Christian Copley SalemUniversity of Nevada, Reno School of Medicine, Department of Pharmacology, Reno, Nevada, USA.
Camellia NabatiUniversity of Nevada, Reno School of Medicine, Department of Pharmacology, Reno, Nevada, USA.
Neda Etezadi-AmoliUniversity of Nevada, Reno School of Medicine, Department of Obstetrics and Gynecology, Reno, Nevada, USA.
Heather R BurkinUniversity of Nevada, Reno School of Medicine, Department of Pharmacology, Reno, Nevada, USA.
University of Nevada, Reno · US

Funding

Tracking and EvaluationU54GM104944 · NIGMS · UNIVERSITY OF NEVADA LAS VEGAS · PI KUMAR, PARVESH · 2013 to 2023
$39.6M
MMP9 Modulation of Uterine Contraction and Birth TimingR01HD100624 · NICHD · UNIVERSITY OF NEVADA RENO · PI BURKIN, HEATHER R · 2020 to 2024
$1.7M
Integrin Regulation of Stretch-Activated Myometrial Signaling During Pregnancy anR00HD067342 · NICHD · UNIVERSITY OF NEVADA RENO · PI BURKIN, HEATHER R · 2013 to 2015
$710k
NICHD NIH HHS R00 HD067342NICHD NIH HHS R01 HD100624NIGMS NIH HHS U54 GM104944
6 · The paper itself

Abstract

Matrix metalloproteinases 2 and 9 (MMP2/9) have previously been shown to be elevated in serum and amniotic fluid from women undergoing preterm birth. We performed experiments to determine the effects of MMP2/9 on uterine contraction and birth timing. Pregnant mice were injected daily with 50 mg/kg of SB-3CT or vehicle control beginning on gestational day 14-18 to determine if MMP2/9 inhibition would affect parturition timing. MMP2/9 expression in human myometrial tissue was determined by Simple Western (Wes) and semiquantitative western blot. Purified MMP2/9 and SB-3CT inhibitor were added to human myometrial strips to determine the effects of MMP2/9 on oxytocin-induced uterine contraction. Parturition was delayed in mice treated with MMP2/9 inhibitor SB-3CT. MMP2/9 protein levels were elevated in preterm laboring uterine myometrium. Gelatinase activity was confirmed in cell extracts and supernatants from immortalized and primary human uterine myometrial cells in culture. Addition of purified MMP2/9 increased the oxytocin-induced contractile response in myometrial tissue strips from pregnant women. In contrast, addition of the MMP2/9 inhibitor SB-3CT decreased the contractile response to oxytocin in a dose-dependent manner. These results suggest abnormal MMP2/9 expression affects the contractile state of the uterine myometrium to promote parturition and that MMP2/9 inhibition attenuates this effect.

Indexed as

AdultAnimalsCells, CulturedDisease ProgressionFemaleHeterocyclic Compounds, 1-RingHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 9MiceMice, Inbred C57BLMyometriumObstetric Labor, PrematureOxytocinParturitionPregnancyHeterocyclic Compounds, 1-RingMatrix Metalloproteinase 2Matrix Metalloproteinase 9MMP2 protein, humanMMP9 protein, humanOxytocinSB 3CT compoundSulfoneshuman reproductionlabormyometriumpregnancyuterus

Identifiers

PMID30951583
PMCPMC6561860
OpenAlexW2926897432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.